State of the Biopharmaceutical Industry 2023

State of the Biopharmaceutical Industry 2023

Summary

In this report, GlobalData examines the business environment and trends that are going to shape the biopharmaceutical industry in 2023. The report highlights the most impactful emerging technologies, industry trends, regulatory trends, and microeconomic factors that are going to impact and dominate the industry throughout 2023.

SynopsisThe pharmaceutical industry is set to face new challenges such as inflation in a post-COVID-19 world.Genomics, RWE, and IO will dominate as the most impactful trends in the biopharmaceutical industry next year.Among the most impactful trends, genomics will be the key focus in 2023.nflation and drug pricing pressures will be the top hindrances for pharmaceutical sector growth.Vertical integration, patent expiry of biologics, mega M&As, and ESG factors are anticipated to have the greatest positive impact on the pharmaceutical industry.Big data and AI will continue to dominate as transformational forces in the healthcare sector in 2023.Across the entire value chain, supply chains and manufacturing will be impacted the most by inflation in 2023.The biopharmaceutical industry is less optimistic about industry growth in the next 12 months compared to previous years.The pharmaceutical industry will continue to pursue its efforts to become more sustainable, with more companies committing to ESG strategies.Oncology, CNS, and infectious diseases will be the dominant areas for clinical trials initiated in 2023.Despite political rhetoric, COVID-19-induced pharmaceutical onshoring may not happen.While already met with skepticism by pharma, the Inflation Reduction Act will have to show if it can live up to its name.Key Highlightsn 2023, economies and industries will continue to deal with inflationary pressures.nflation will disrupt pharmaceutical manufacturing and supply chains.Genomics is the trend that will continue to have the greatest impact on the pharmaceutical industry in 2023.nflation together with drug pricing and reimbursement-related concerns will be the leading impediment to industry growth.Vertical integration, patent expiry of biologics, mega M&As, and ESG factors will have the most positive impacts on industry.While less than in previous years, the biopharmaceutical industry is still optimistic about its growth in 2023.ScopeBenchmark the impact of major themes on the biopharmaceutical industry in 2023, including: emerging technologies, regulatory trends, macroeconomic trends, industry trends.dentify themes that will have the greatest positive or negative impact in 2023.Capture opinions on these themes from industry respondents.Assess the impact of COVID-19 on the biopharmaceutical sector.Explore how inflation will affect the pharmaceutical industry in 2023.Reasons to BuyStay up to date with the major emerging technologies, regulatory, macroeconomic, and industry trends that will impact the pharmaceutical industry in 2023.Explore how the biopharmaceutical landscape has changed.dentify the most impactful anticipated regulatory approvals and drug launches in the industry in 2023.Gain insight into the regulatory and microeconomics trends that will have positive and negative effects on the biopharmaceutical industry.dentify emerging industry trends and innovations to gain a competitive advantage.